Is VO2 Max Really the Best Predictor of How Long You’ll Live? | Barbell Medicine

Why It Matters

Relying on a single metric like VO2 max can misguide training and health decisions; a multidimensional fitness assessment better predicts longevity and supports more effective, individualized exercise prescriptions.

Key Takeaways

• VO2 max differs from broader cardiorespiratory fitness measures
• Most longevity studies use exercise tolerance, not direct VO2 max
• Targeting VO2 max alone may neglect other health‑relevant adaptations
• Performance‑based tests can serve as practical fitness benchmarks
• Metrics help monitor progress, but should not replace diverse training

Summary

The Barbell Medicine panel tackles a contentious claim: whether VO2 max is the premier predictor of lifespan. Dr. Eric Toppel points out that most longevity research relies on estimated exercise tolerance—METs, treadmill time, or sub‑maximal tests—rather than direct VO2 max measurements, a nuance often glossed over by Dr. Peter Aia’s popular guidelines.

The discussion highlights three core insights. First, VO2 max and overall cardiorespiratory fitness are distinct; the former captures maximal oxygen uptake under laboratory conditions, while the latter reflects a broader set of physiological adaptations. Second, the evidence linking fitness to longevity stems from performance‑based metrics, not the precise VO2 max values Aia promotes. Third, zeroing in on VO2 max as a singular target can sideline other valuable training modalities that improve peripheral and central cardiovascular health.

Panelists cite specific studies—a 2022 Gemma Network analysis using METs and a 1989 JAMA treadmill‑time trial—to illustrate how performance data map onto VO2 max percentiles. They also draw analogies to strength training, noting that obsessing over grip strength or a 5‑RM squat would similarly narrow training scope. Barbell Medicine’s “Vital 5” framework, which includes multiple field tests across modalities, exemplifies a more balanced approach.

The takeaway for clinicians, coaches, and biohackers is clear: use VO2 max as one useful benchmark, but embed it within a suite of fitness assessments and varied aerobic protocols. This prevents over‑optimization of a single metric and ensures training programs address the full spectrum of cardiovascular adaptations that drive healthspan and longevity.

Original Description

VO2 max is everywhere in longevity content right now — and for good reason. But there’s a real scientific problem with how it’s being cited, and it has practical implications for how you approach training.

Dr. Jordan Feigenbaum and Dr. Austin Baraki break down:

• The actual difference between VO2 max and cardiorespiratory fitness (CRF)

• Why most of the longevity studies Peter Attia cites measure MET performance — not VO2 max (JAMA 2022, JAMA 1989)

• Whether Attia’s specific percentile targets are evidence-based — and whether that matters

• Why having a measurable target matters more than which test you use

• The Barbell Medicine Vital Five framework for monitoring CRF

The bottom line: the direction is right, the precision is overstated — and that’s actually a useful distinction when building a training program.

Timestamps:

0:00 — Introduction

1:53 — Is VO₂ Max Really the Best Longevity Metric? Goodhart’s Law Applied

2:20 — What Longevity Studies Actually Measure: MET Performance, Not VO₂ Max

3:49 — The CRF–Longevity Relationship Is Clear — Collapsing to VO₂ Max Alone Is Shortsighted

5:43 — Jordan’s Take: Why Any Measurable CRF Target Beats No Target

7:49 — The Goodhart’s Law Problem: What Happens When VO₂ Max Becomes THE Metric

9:44 — Bottom Line: Metrics Are Useful, But Don’t Collapse Everything to One

Next Steps:

For evidence-based resistance training programs: barbellmedicine.com/training-programs

For individualized training consultation: barbellmedicine.com/coaching

Explore our full library of articles on health and performance: barbellmedicine.com/resources

To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/

To consult with Drs. Baraki or Feigenbaum email us at [e-mail]

Resources:

• JAMA Network Open, 2022 — Exercise capacity assessed by METs and cardiovascular outcomes. Referenced by Austin as a “frequently cited” study showing longevity studies measure MET performance, not direct VO₂ max. https://www.jacc.org/doi/10.1016/j.jacc.2022.05.031

• JAMA, 1989 — Treadmill time as a performance-based CRF measure and all-cause mortality. Referenced by Austin alongside the 2022 study as evidence that longevity research uses performance tests, not VO₂ max. (Blair SN et al.) https://jamanetwork.com/journals/jama/fullarticle/379243

• Attia P. “Outlive: The Science and Art of Longevity” (2023) — Source of the VO₂ max percentile targets discussed. Austin’s position: Attia is “directionally accurate” but overstates the specificity of VO₂ max as a metric. https://peterattiamd.com/outlive/

• Topol EJ — Cardiologist who has publicly critiqued Attia’s VO₂ max longevity claims; referenced by Jordan as support for the CRF-vs-VO₂max distinction. https://erictopol.substack.com/p/the-flawed-v02-max-craze

• Goodhart’s Law (Goodhart C, 1975) — “When a measure becomes a target, it ceases to be a good measure.” Austin alludes to this principle (without naming it) as the core problem with singularly chasing VO₂ max.

• Barbell Medicine Vital Five —https://www.barbellmedicine.com/vital-5-action-plan/